The Latest Breaking News on Pharma

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

Many Sudanese activists are becoming concerned about the spread of the highly addictive synthetic drug methamphetamine, nicknamed “ice” or “Satan”. In light of the growing issue, some have started campaigns to raise awareness and opened rehabilitation centres. They say the government is failing to do enough.

The first significant stage of post-Roe abortion litigation is underway and focuses heavily on abortion pills. GenBioPro, a pharmaceutical company that makes the drug mifepristone, has asked a federal court to declare that West Virginia’s anti-abortion law is inconsistent with the Federal Drug Administration’s determination that the pill is safe…

Hong Kong will ban CBD starting Wednesday, labeling it a “dangerous drug.”

The Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements

Over 4,000 workers could see their pay reduced due to shift changes

Nitrous oxide is one of the most commonly-used drugs among 16 to 24-year-olds in England and can have damaging side-effects, the Home Office said.

The retailer is proposing that some overnight shifts at 184 stores are moved to the daytime, putting 211 night shift manager roles at risk

A boss at Asda said the retail sector is 'evolving at pace'

The retailer also said it will cut hours at in-store Post Office stores and close seven pharmacies.

The vaccine has been developed by India's Bharat Biotech. It will be available to the government for ₹ 325 per dose, but it will cost ₹ 800 to private hospitals. Read further on Dynamite News: